Neuralink, the brain-computer interface startup spearheaded by Elon Musk, has successfully raised $280 million in a Series D funding round. The round was orchestrated by Peter Thiel’s Founders Fund, marking another collaboration between Thiel and Musk, following previous investments in ventures like SpaceX and The Boring Company.
Valuation and Growth
While Neuralink opted not to disclose its current valuation, speculations in June pegged the company’s worth at an estimated $5 billion. The Founders Fund is no stranger to investing in promising tech startups. Their portfolio showcases investments in major companies such as Facebook, Spotify, Palantir, and Airbnb, signaling their dedication to fueling technological advancements. Their manifesto underscores their belief in technology as a primary growth catalyst in modern societies.
About Neuralink: Bridging Minds and Machines
Initiated in 2016 by Musk and a team of elite engineers and scientists in Fremont, Neuralink’s mission revolves around pioneering brain-computer interfaces (BCIs). These BCIs are designed for implantation, facilitating a seamless connection between the brain and external computers. Neuralink’s aspirations are two-fold: addressing pressing medical needs and, in the long run, enhancing human potential.
Earlier in May, the U.S. Food and Drug Administration greenlit Neuralink for human trials, a monumental step for the company. Expressing his enthusiasm, Scott Nolan, a partner at Founders Fund, lauded Neuralink’s advancements, emphasizing their “science fiction” quality and highlighting the company’s unique position in the tech space. Nolan’s sentiments were shared on his X profile.
Joining the Neuralink Mission
In a related development, Neuralink is on the hunt for adept professionals ready to tackle formidable engineering tasks, primarily aimed at reviving vision and mobility capabilities. Those possessing expertise in technology, operations, or safety are encouraged to explore opportunities via Neuralink’s official platform.